Verified peer comparison
HCA vs LLY
HCA Healthcare, Inc. compared with Eli Lilly and Company. This page compares both source-verified company profiles and does not introduce an unverified price target.
HCA
HCA Healthcare, Inc.
$189.43
- Open
- --
- High
- --
- Low
- --
- Market Cap
- --
LLY
Eli Lilly and Company
$782.10
- Open
- --
- High
- --
- Low
- --
- Market Cap
- --
Company-specific comparison
Business exposure
HCA: Health Care Facilities
LLY: Pharmaceuticals
Upside lens
HCA: Population growth and aging in HCA markets can support inpatient, outpatient and emergency demand. New beds, outpatient sites and service lines can capture demand in attractive local markets. Recruiting, retention and scheduling tools can reduce reliance on expensive contract labor.
LLY: obesity drug adoption and pipeline expansion
Risk lens
HCA: Medicare, Medicaid and commercial payment changes can lag hospital cost inflation. Nurse and physician shortages can raise wages, constrain capacity and affect care quality. Billing investigations, malpractice claims and cybersecurity incidents can create material costs.
LLY: supply constraints and valuation expectations
Verified sources
HCA Healthcare Reports First Quarter 2026 ResultsHCA Healthcare, Inc. · earningsVerified
HCA Healthcare, Inc. Investor RelationsHCA Healthcare, Inc. · companyVerified
Fetched: 7/12/2026, 12:00:00 AM UTC
Open original sourceHCA Healthcare SEC filings and company factsU.S. Securities and Exchange Commission · filingVerified
Lilly Reports First-Quarter 2026 Financial ResultsEli Lilly and Company · earningsVerified
Eli Lilly Investor RelationsEli Lilly and Company · companyVerified
Fetched: 7/11/2026, 12:00:00 AM UTC
Open original sourceForm 10-Q for the Quarter Ended March 31, 2026Eli Lilly and Company · filingVerified
LLY editorial research profileAlphaVue Research · editorialVerified
Fetched: 7/11/2026, 12:00:00 AM UTC